Investor Hub

Novavax, Inc. is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases.

Latest investor presentation
Latest investor presentation
Latest quarterly earnings
Latest quarterly earnings
Latest clinical presentation
Latest clinical presentation
Latest publications, posters & presentations
Our research
Annual report
Annual report
NASDAQ:NVAX
Loading data...
Stock details
Latest press releasesEvents & presentationReports & financialsSEC filingsStock details & analyst coverage
Past Events
Apply filter
Filter

Filter

Clear filter
Baird 2023 Global Healthcare Conference
Tuesday, September 12, 2023
10:15am - 10:45am EDT
Virtual webcast
H.C. Wainwright 25th Annual Global Investment Conference:
Monday, September 11, 2023
4:30pm - 5:00pm EDT
Virtual webcast
Novavax Second Quarter 2023 Financial Results
Tuesday, August 8, 2023
8:30am EDT
Virtual webcast
Second Quarter 2023 Financial Results & Operational Highlights
2023 Annual Meeting of Stockholders
Tuesday, July 11, 2023
8:30am EDT
Virtual webcast
2022 Annual Report
2023 Proxy Statement
Jefferies Global Healthcare Conference
Thursday, June 8, 2023
9:00am - 9:25am EDT
Virtual webcast
BofA Securities 2023 Health Care Conference
Thursday, May 11, 2023
1:00pm - 1:30pm EDT
Virtual webcast
Novavax First Quarter 2023 Financial Results
Tuesday, May 9, 2023
8:30am - 9:30am EDT
Virtual webcast
First Quarter 2023 Financial Results & Operational Highlights
Novavax to Participate in TD Cowen's 43rd Annual Health Care Conference
Wednesday, March 8, 2023
9:50am - 10:20am EST
Virtual webcast
Novavax Fourth Quarter 2022 Financial Results
Tuesday, February 28, 2023
4:30pm - 5:30pm EST
Virtual webcast
Fourth Quarter 2022 Financial Results & Operational Highlights
41st Annual J.P. Morgan Healthcare Conference
Monday, January 9, 2023
8:15pm - 8:55pm EST
Virtual webcast
Download PDF for this event
BofA Securities 2022 Virtual Biotech SMID Cap Conference
Wednesday, December 7, 2022
9:10am - 9:35am EST
Jefferies London Healthcare Conference
Wednesday, November 16, 2022
3:35am - 4:05am EST
Why invest with us

We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases.

Learn more
Lisa Dunkle

For much of my four-decade career, I’ve worked with biotech companies trying to solve significant health challenges, including HIV. Novavax is uniquely positioned to help end this pandemic with our protein-based vaccine. I believe in NVX-CoV2373 so much.
I came out of retirement to join the fight.

Lisa Dunkle
Vice President, Global Medical Lead for Coronavirus Vaccine
Governance documents
Get notifications for investor updates

Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.

Go to email subscription
Investor inquiries

Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at [email protected]

Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.